Testing effectiveness (Phase 2)Study completedNCT00051025
What this trial is testing
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
Who this might be right for
Non-Hodgkin's LymphomaLymphoma, B-cellLymphoma, Low-grade
Eisai Inc. 9